Evidence map›Paper›PMID 34305609›Full record

ReviewFrontiers in pharmacology2021

Caspase-9: A Multimodal Therapeutic Target With Diverse Cellular Expression in Human Disease.

Maria I Avrutsky, Carol M Troy

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 149 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. BlackenedMolecules (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. The therapeutic potential ofAvicenna journal of phytomedicine · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Maria I AvrutskyDepartment of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.
Carol M TroyDepartment of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.
Columbia University · US

Funding

Vision Sciences Training GrantT32EY013933 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Carol A. Mason, CAROL M TROY · 2001 to 2026
$5.3M
NEURONAL DEGENERATION: MECHANISMS AND PREVENTIONR01NS035933 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TROY, CAROL M · 2004 to 2007
$1.5M
Generation of caspase-9 cell specific inducible knockout mice for the study of mechanisms of cerebral edemaR03NS099920 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TROY, CAROL M · 2017 to 2018
$160k
NEI NIH HHS T32 EY013933NINDS NIH HHS R01 NS035933NINDS NIH HHS R03 NS099920
6 · The paper itself

Abstract

Caspase-9, a cysteine-aspartic protease known for its role as an initiator of intrinsic apoptosis, regulates physiological cell death and pathological tissue degeneration. Its nonapoptotic functions, including regulation of cellular differentiation/maturation, innate immunity, mitochondrial homeostasis, and autophagy, reveal a multimodal landscape of caspase-9 functions in health and disease. Recent work has demonstrated that caspase-9 can drive neurovascular injury through nonapoptotic endothelial cell dysfunction.

Indexed as

apoptosiscancercardiomyopathycardiovascular diseasecaspase-9innate immunityneurodegenerationretina

Identifiers

PMID34305609
PMCPMC8299054
OpenAlexW3178463557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.